SNGX 2.27 Updated: 09-24-2017 $SNGX Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
23
SNGX 2.27 Updated: 09-24-2017 $SNGX
Last Trade: 9/22/2017

Last 2.27   - 
Open 2.20
Previous Close 2.27
Day High / Low 2.27 / 2.20
Year High / Low 8.50 / 1.90
Volume 33,566
Projected Volume 33566 (92%)
# of Trades / Projected 99 / 99
Dividend / Yield - / 0.00%
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle BULLISH
Volatility Today MEDIUM
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 97%
From 80 Day High 79%
From 150 Day High 55%
From 40 Day Low 113%
From 80 Day Low 115%
From 150 Day Low 115%
Pivot Analysis
Price Pivot $ 2.25
Day Resistance 1 $ 2.29
Day Support 1 $ 2.22
Day Resistance 2 $ 2.32
Day Support 2 $ 2.18
Consolidations
Short Term NO
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 36,498
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 359,514
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics bearish
RSI bearish
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday MEDIUM
10 Day Volatility INCREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Recursion and Exscientia Unite for Groundbreaking Drug Discovery

Updated Category News Views 96

Recursion and Exscientia Join Forces for Advanced Drug Discovery Two trailblazers in the field of AI-driven drug discovery, Recursion and Exscientia, have officially merged to create a robust entity focused on transforming the landscape of drug development. This amalgamation marks a significant milestone in their shared mission to expedite the discovery of innovative...

Continue Reading
Innovative Ergodyne Type 2 Helmets: Style Meets Safety

Updated Category News Views 402

Introducing Ergodyne's Type 2 Safety Helmets Ergodyne has unveiled its latest innovation in safety gear, the new Type 2 Safety Helmets, designed to balance familiar aesthetics with enhanced protection. These helmets aim to ease worker reluctance towards new equipment by merging the classic design of a full brim hard hat with the advanced safety features that Type 2...

Continue Reading
Palantir Technologies: Navigating Market Challenges Ahead

Updated Category News Views 227

Palantir Technologies: An Overview of Current Stock Trends Palantir Technologies (NASDAQ: PLTR) has recently experienced fluctuations in its stock prices, especially after being announced as a new member of the NASDAQ 100. In the days following this announcement, investors observed a pullback of more than 5%, which can be closely tied to broader market trends influenced...

Continue Reading
Citi Downgrades Woodside Stock Due to Persisting Investor Worries

Updated Category News Views 75

Citi dropped a bomb on Woodside Energy Group back when they revised their outlook, cutting the price target from AUD 24.50 to AUD 23.00 while keeping that pesky Sell rating in play. Why? Well, investor nerves around dividends and looming corporate mergers were in the air like a bad hangover at the trading desk. Citi’s Reckoning: EPS Boost or Dividend Squeeze? The update...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit: Key Details Inside

Updated Category News Views 127

Understanding the Class Action Lawsuit Against Lantheus Holdings, Inc. Investors in Lantheus Holdings, Inc. (NASDAQ: LNTH) should be aware of a class action lawsuit that has been initiated, which could represent a significant opportunity for those who believe they've suffered losses due to the company's actions. This notable legal action is spearheaded by the reputable...

Continue Reading